204 related articles for article (PubMed ID: 35714355)
1. Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes.
Montaser E; Fabris C; Kovatchev B
Diabetes Technol Ther; 2022 Nov; 24(11):797-804. PubMed ID: 35714355
[No Abstract] [Full Text] [Related]
2. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
3. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
[TBL] [Abstract][Full Text] [Related]
4. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
[TBL] [Abstract][Full Text] [Related]
5. Optimal Coefficient of Variance Threshold to Minimize Hypoglycemia Risk in Individuals with Well-Controlled Type 1 Diabetes Mellitus.
Yoo JH; Yang SH; Jin SM; Kim JH
Diabetes Metab J; 2024 May; 48(3):429-439. PubMed ID: 38476023
[TBL] [Abstract][Full Text] [Related]
6. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
[TBL] [Abstract][Full Text] [Related]
7. Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy.
Rodbard D
Diabetes Technol Ther; 2021 Oct; 23(10):692-704. PubMed ID: 34086495
[TBL] [Abstract][Full Text] [Related]
8. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
[TBL] [Abstract][Full Text] [Related]
9. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
Gómez AM; Henao DC; Imitola Madero A; Taboada LB; Cruz V; Robledo Gómez MA; Rondón M; Muñoz-Velandia O; García-Jaramillo M; León Vargas FM
Diabetes Technol Ther; 2019 Aug; 21(8):430-439. PubMed ID: 31219350
[No Abstract] [Full Text] [Related]
10. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
11. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
[TBL] [Abstract][Full Text] [Related]
12. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
[TBL] [Abstract][Full Text] [Related]
13. Significance of the CGM metric of time in range in children and adolescents with type 1 diabetes.
Urakami T
Endocr J; 2022 Sep; 69(9):1035-1042. PubMed ID: 36002301
[TBL] [Abstract][Full Text] [Related]
14. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control.
Yoo JH; Kim JH
Diabetes Metab J; 2020 Dec; 44(6):828-839. PubMed ID: 33389957
[TBL] [Abstract][Full Text] [Related]
15. Continuous Glucose Monitoring-Based Composite Metrics: A Review and Assessment of Performance in Recent-Onset and Long-Duration Type 1 Diabetes.
Donaldson LE; Vogrin S; So M; Ward GM; Krishnamurthy B; Sundararajan V; MacIsaac RJ; Kay TWH; McAuley SA
Diabetes Technol Ther; 2023 Jul; 25(7):497-506. PubMed ID: 37010375
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.
Toschi E; Slyne C; Sifre K; O'Donnell R; Greenberg J; Atakov-Castillo A; Carl S; Munshi M
Diabetes Care; 2020 Oct; 43(10):2349-2354. PubMed ID: 32461211
[TBL] [Abstract][Full Text] [Related]
17. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
Rodbard D
Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
[TBL] [Abstract][Full Text] [Related]
18. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
19. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
[TBL] [Abstract][Full Text] [Related]
20. Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses.
Monnier L; Colette C; Owens D
Diabetes Metab; 2021 Mar; 47(2):101173. PubMed ID: 32561428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
